食管癌放疗抵抗研究现状OA
Advances in Understanding Radiotherapy Resistance in Esophageal Cancer
食管癌是全球最常见的恶性肿瘤之一,其发病率和死亡率均居高不下,对人类的健康状况产生了巨大威胁.放疗是食管癌治疗策略中的重要一环.放疗抵抗是指肿瘤细胞对放疗带来的效应产生耐受或反应降低,从而导致食管癌复发、转移及预后不良.近年来,食管癌放疗抵抗已成为肿瘤治疗研究领域的一个核心议题.本文旨在综述食管癌放疗抵抗的潜在机制、影响因素及可能的应对策略,为临床开展个性化精准治疗提供新的参考.
Esophageal cancer is one of the most common malignant tumors worldwide,with persistently high incidence and mortality rates,thus posing a major threat to human health.Radiotherapy is a key component of the comprehensive treat-ment strategy for esophageal cancer.Radioresistance refers to the phenomenon in which tumor cells develop tolerance or at-tenuated responses to radiotherapy,resulting in tumor recurrence,metastasis,and poor prognosis.In recent years,radiore-sistance in esophageal cancer has become a research hotspot in the field of oncology.This article reviews the potential mecha-nisms,influencing factors,and potential strategies to overcome radioresistance in esophageal cancer,aiming to provide new insights for the implementation of individualized and precise clinical treatment.
张琨;许恬;汪建林
213000 江苏 常州,南京医科大学附属第三医院(常州市第二人民医院)放疗科213000 江苏 常州,南京医科大学附属第三医院(常州市第二人民医院)放疗科213000 江苏 常州,南京医科大学附属第三医院(常州市第二人民医院)放疗科
医药卫生
食管癌放疗放疗抵抗DNA损伤修复肿瘤微环境
Esophageal cancerRadiotherapyRadiation resistanceDNA damage repairTumor microenvironment
《肿瘤预防与治疗》 2026 (5)
401-408,8
This study was supported by grants from Changzhou Health Commission(No.ZD202313,No.2022CZBJ070)and Changzhou Medical Center of Nanjing Medical University(No.CMCC202401). 常州市卫生健康委员会科技项目(编号:ZD202313)常州市"十四五"高层次卫生人才培养工程拔尖人才项目(编号:2022CZBJ070)南京医科大学常州医学中心临床项目(编号:CMCC202401)
评论